项目名称: 纳米蛋白纤维传感器作癌症标记物的检测及其于疾病诊断中的应用
项目编号: No.21205006
项目类型: 青年科学基金项目
立项/批准年度: 2013
项目学科: 分析化学
项目作者: 李红荣
作者单位: 香港浸会大学深圳研究院
项目金额: 25万元
中文摘要: 最近,微核糖核酸(miRNA)被视作一种新型的细胞调节剂。有强力的科研证据证明人体内miRNA水平的异常表达与多种不同疾病,如癌症、糖尿病、心血管病等,都有着密切的关系。因此,miRNA能够作为一种疾病的生物标记物,透过测量miRNA的水平及其表达可能有助诊断早期疾病的形成。可惜,基于miRNA的短序列以及其于体内极低的浓度令传统的定量及表达谱分析带来很大挑战。本项目拟开发一种直接、超敏、而且省却样品预处理的多元miRNA检测方法。自组制淀粉样蛋白纤维将作为检测靶miRNA的生物传感器。作为检测探针的锁核酸分子信标将捕捉溶液中的靶miRNA,而杂交体将于蛋白纤维上预富集从而提高荧光信号于荧光显微镜下的信噪比。为提高检测平台的应用能力,鼻咽癌病人的血液及唾液样品将会被收集作为此平台的临床测试物。研究成功的话,此高敏且准确的平台将为生物医学研究及临床检测应用上带来全新的发展。
中文关键词: 淀粉样纤维;生物标记物;超高灵敏度;无需样品预处理;直接分析检测
英文摘要: MicroRNA (miRNA) has recently emerged as a new and important class of cellular regulators. Strong evidence that aberrant expression of miRNA is associated with a broad spectrum of human diseases, such as cancer, diabetes, cardiovascular and psychological disorders. However, the short length and low abundance of miRNA place great challenges for conventional techniques in the miRNA quantitation and expression profiling. In this work, we propose a direct and ultrasensitive and multiplex detection assay for miRNA without sample amplification. A self-assembled protein nanofibril acts as an online preconcentrating sensor to the target miRNA. Lock-nucleic acid (LNA) modified molecular beacon (MB) is the probe and signal generator. This work will further extend to clinical samples of Nasopharyngeal Carcinoma (NPC) patients' tumor tissue, as well as blood and saliva such that a non-invasive sampling approach is adapted for early clinical disease diagnosis and prognosis, and clinical new drugs testing. The success of this project will certainly open up new avenues for development of highly sensitive and accurate detection systems to both biomedical researches and a wide variety of clinical applications.
英文关键词: Amyloid fibrils;Disease biomarkers;Ultrasensitive;Sample-pretreatment free;Direct detection